Novartis AG (NVS)

NYSE

$149.56

Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.

Sector:

Industry:

68 analysts

Buy

Target: $154.56 (+3.34%)

Market Cap

$289B

Dividends 5Y CAGR

+21.01%

Profit Margin

23.3%

Forward P/E

17.42

Adjust inflation

Log

Valuation

Market Cap$289B

P/E21.60

Forward P/E17.42

PEG2.32

P/S5.07

P/B7.60

Profitability

Total Revenue (TTM)$56B

Gross Profit (TTM)$43B

EBITDA$22B

Profit Margin23.3%

Operating Margin31.3%

EPS$6.98

Financial Health

Debt-to-Equity122%

Free Cash Flow Yield5.66%

Dividend Yield3.08%

Growth & Risk

EPS 5Y CAGR+14.96%

Revenue 5Y CAGR+2.36%

FCF 5Y CAGR+9.71%

Dividends 5Y CAGR+21.01%

Beta (5Y)0.23

Sharpe Ratio1.32